{"id":209002,"name":"MODERNA US INC.","slug":"moderna-us-inc","state":"MA","country":"United States of America","description":"Pharmaceuticals","totalSpending":1550000,"filings":22,"yearlySpending":[{"year":2021,"income":200000},{"year":2022,"income":310000},{"year":2023,"income":400000},{"year":2024,"income":320000},{"year":2025,"income":320000}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"},{"code":"FOR","display":"Foreign Relations"}],"firms":["BROWNSTEIN HYATT FARBER SCHRECK, LLP"],"lobbyists":["CARMENCITA WHONDER","MARC LAMPKIN","ARACELI GUTIERREZ","NADEAM ELSHAMI","EMILY FELDER","LAKEITHA ANDERSON","SAMANTHA CARL-YODER","EDWARD ROYCE","DOUGLAS MAGUIRE","ALFRED MOTTUR","ANDREW USYK","MARCKIA HAYES","BRIAN MCGUIRE","ADAM STEINMETZ","JONATHAN TOWERS","BRANDT ANDERSON","TRAVIS NORTON","ARI ZIMMERMAN","DEEMA TARAZI"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","State, Dept of (DOS)","Health & Human Services, Dept of (HHS)","Natl Security Council (NSC)","Centers For Disease Control & Prevention (CDC)","Executive Office of the President (EOP)","U.S. Agency for International Development (USAID)","White House Office"],"sampleDescriptions":["Issues related to mRNA drug discovery, drug development, and vaccine technologies","Issues related to mRNA drug discovery, drug development, and vaccine technologies","Issues related to mRNA drug discovery, drug development, and vaccine technologies","Issues related to international vaccine deployment","Issues related to mRNA drug discovery, drug development, and vaccine technologies"]}